Navigation Links
Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
Date:12/17/2008

A Complimentary Continuing Medical Education Newsletter Series for Physicians

VOORHEES, N.J., Dec. 17 /PRNewswire/ -- Management of Clostridium difficileinfection (CDI) in geriatric and pediatric populations can be challenging and complicated. Because of the observed increase in CDI incidence in many age groups, healthcare professionals need to be especially attuned to the individual needs of these patient populations.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing medical education (CME) newsletter series entitled Current Concepts in Clostridium difficile Infection. The third issue of this three-part newsletter series has just been released and is entitled Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients. The newsletter series is supported by an educational grant from ViroPharma Incorporated.

Expert faculty for this CME activity include Ciaran P. Kelly, MD, Associate Professor of Medicine at Harvard Medical School, and Director of Gastroenterology Fellowship Training and Chief, Herman L. Blumgart Internal Medicine Firm at Beth Israel Deaconess Medical Center in Boston, Massachusetts; and Vivian G. Loo, MD, MSc, FRCPC, Associate Professor of Medicine at McGill University and Chief of the Department of Microbiology at McGill University Health Centre in Montreal, Quebec, Canada.

Physicians can download or order online each of the three newsletters in the Current Concepts in Clostridium difficile Infection series: A Focus on Recurrent Disease, A Focus on Severe Disease, and A Focus on Geriatric and Pediatric Patients by visiting www.rmei.com/CDInewsletters.

"Quality continuing medical education is vital to developing and increasing knowledge and skills and enhancing patient care," says RMEI President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure
2. CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb
3. Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers
4. Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect
5. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
6. The CoverMe Foundation Responds to Current U.S. Economic Crisis Offering Healthcare Coverage Solutions to Uninsured
7. Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest
8. Survey finds widespread dissatisfaction with current health care payment system
9. New topical approach to treating nail fungus circumvents problems with current therapy
10. Response Biomedical Announces Insider Participation in Current Financing
11. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... is pleased to announce Westchester resident Lauren C. Enea has joined the firm as ... firm, will concentrate her practice in elder law, Medicaid planning and applications, and Wills, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, ... their training and leads programs. , In February, 2017, Empower Brokerage introduced their ... Performance Partners is designed to teach how to maximize their sales efforts, as ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The Dog ... dog who lives his life to the fullest, as God intended. “The Adventures of ... Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary  ... According to new data published Arcview ... legal cannabis market is projected to continue to grow at ... the current presidential administration. The report created by Arcview,s data ... growth in this industry are the passage and subsequent implementation ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: